Table 3.

Pregnancy-related outcomes of the patients in the highly purified human menopausal gonadotropin (hp-hMG) and recombinant follicle-stimulating hormone (rFSH) groups.^*

Outcome	hp-hMG (n = 30)	rFSH (n = 30)	P value
Embryos transferred per >14 mm oocyte	61/113 (54.0)	47/105 (44.8)	0.174
Clinical pregnancy rate per cycle initiated	12/39 (30.8)	10/34 (29.4)	0.900
Implantation rate per transferred embryo	38/61 (62.3)	29/47 (61.7)	0.950
Miscarriage rate per pregnancy	4/12 (33.3)	3/10 (30.0)	0.867
Live birth rate per pregnancy	2/12 (16.7)	1/10 (10)	0.650

^⁎Values are presented as n/N (%).